Voyageur Pharmaceuticals (CVE:VM) Trading Up 21.2% – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares shot up 21.2% during trading on Thursday . The stock traded as high as C$0.20 and last traded at C$0.20. 216,394 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 534,421 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Down 10.0 %

The business has a 50 day moving average of C$0.11 and a two-hundred day moving average of C$0.08. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The stock has a market capitalization of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.